PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum

Peng Du,Kaifeng Luo,Guoyong Li,Jisheng Zhu,Qi Xiao,Yong Li,Xingjian Zhang

DOI: https://doi.org/10.7150/ijms.71614

2022-01-01

International Journal of Medical Sciences

Abstract:[This corrects the article DOI: 10.7150/ijms.62467.].

medicine, general & internal

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Liu Yang,Yang Guo,Xin Liu,Tongtong Wang,Xiangmin Tong,Kefeng Lei,Jiahui Wang,Dongsheng Huang,Qiuran Xu

DOI: https://doi.org/10.7150/jca.76866

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.25569.].

oncology
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis

Peng Du,Kaifeng Luo,Guoyong Li,Jisheng Zhu,Qi Xiao,Yong Li,Xingjian Zhang

DOI: https://doi.org/10.7150/ijms.62467

2021-01-01

International Journal of Medical Sciences

Abstract:Background: Protein arginine methyltransferase 4 (PRMT4) has been reported to play a role in several common cancers; however, the function and mechanism of PRMT4 in hepatocellular carcinoma (HCC) are not fully understood. This study aimed to investigate the role and mechanism of PRMT4 in the progression of HCC. Methods: PRMT4 expression and clinicopathological characteristics were investigated using an HCC tissue microarray (TMA) consisting of 140 patient samples analyzed by immunohistochemistry. CCK-8, crystal violet and Transwell assays were used to determine cell proliferation, colony formation, migration, and invasion of HCC cell lines in which PRMT4 was overexpressed or downregulated. The underlying mechanism of PRMT4 function was explored by Western blot assays. Results: PRMT4 was highly expressed in HCC tumor tissues compared to adjacent nontumor tissues. PRMT4 expression was significantly associated with alpha-fetoprotein levels, tumor size, satellite nodules, and microvascular invasion. Patients with higher PRMT4 expression had a shorter survival time and higher recurrence rate. Functional studies demonstrated that PRMT4 overexpression promoted HCC cell proliferation, migration, and invasion in vitro, while knocking down PRMT4 inhibited these malignant behaviors. Additional results revealed that PRMT4 promoted the progression of HCC cells via activation of the AKT/mTOR signaling pathway. Furthermore, inhibition of the AKT/mTOR signaling by MK2206 or rapamycin significantly attenuated PRMT4-mediated malignant phenotypes. Conclusions: This study suggests that PRMT4 may promote the progression of HCC cells by activating the AKT/mTOR signaling pathway, which may be a valuable biomarker and potential target for HCC.

medicine, general & internal
LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer: Erratum

Biao Zheng,Jianhua Qu,Kenoki Ohuchida,Haimin Feng,Stephen Jun Fei Chong,Zilong Yan,Yicui Piao,Peng Liu,Nan Sheng,Daiki Eguchi,Takao Ohtsuka,Kazuhiro Mizumoto,Zhong Liu,Shazib Pervaiz,Peng Gong,Masafumi Nakamura

DOI: https://doi.org/10.7150/thno.68023

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47001.].

medicine, research & experimental
Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Haiyan Wang,Liang Duan,Zhengyu Zou,Huan Li,Shimei Yuan,Xian Chen,Yunyuan Zhang,Xueru Li,Hui Sun,He Zha,Yan Zhang,Lan Zhou

DOI: https://doi.org/10.7150/ijms.69070

2022-01-01

International Journal of Medical Sciences

Abstract:[This corrects the article DOI: 10.7150/ijms.8128.].

medicine, general & internal
circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum

Huan Liu,Guanghui Hu,Zaoyu Wang,Qunlong Liu,Jin Zhang,Yonghui Chen,Yiran Huang,Wei Xue,Yunfei Xu,Wei Zhai

DOI: https://doi.org/10.7150/thno.69378

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47239.].

medicine, research & experimental
EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Chen Yi,Xiliu Zhang,Hongyu Li,Guanhui Chen,Binghui Zeng,Yiming Li,Chao Wang,Yi He,Xun Chen,Zixian Huang,Dongsheng Yu

DOI: https://doi.org/10.7150/jca.87278

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.59331.].

oncology
Erratum: Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway

Jian Jiang,Yaodong Chen,Tianxiu Dong,Minlu Yue,Yu Zhang,Tingting An,Jiuwei Zhang,Pengfei Liu,Xiuhua Yang

DOI: https://doi.org/10.3892/ol.2019.10856

Abstract:[This corrects the article DOI: 10.3892/ol.2019.10123.].
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].
[Corrigendum] PRIMA‐1 met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‐ULK1‐Vps34 signaling cascade

Xiao-Lan Li,Jianbiao Zhou,Chen-Jing Xia,Han Min,Zhong-Kai Lu,Zhi-Rong Chen

DOI: https://doi.org/10.3892/or.2024.8703

2024-01-18

Oncology Reports

Abstract:Following the publication of the above article, the authors contacted the Editorial Office to explain that the strips of β‐actin, LC3 and p62 proteins of the RKO cell line shown in Fig. 2A and B, and those of the SW620 cell line shown in Fig. 3A and B, were assembled in these figures incorrectly. To rectify the presentation of these two figures, the authors proposed that they replace the strips of β‐actin and p62 proteins in the original Figs. 2B and 3B with the β‐actin bands from one of the repeated western blotting experiments. The revised and corrected versions of Figs. 2 and 3 are shown on the next page. The authors wish to emphasize that these corrections do not grossly affect either the results or the conclusions reported in this work. The authors all agree to the publication of this Corrigendum, and are grateful to the Editor of Oncology Reports for granting them the opportunity to correct the errors that were made during the assembly of these figures. Lastly, the authors apologize to the readership for any inconvenience these errors may have caused. [Oncology Reports 45: 86, 2021; DOI: 10.3892/or.2021.8037]

oncology
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis: Erratum

Xiao-Peng Tian,Chen-Yuan Wang,Xiao-Han Jin,Mei Li,Feng-Wei Wang,Wei-Juan Huang,Jing-Ping Yun,Rui-Hua Xu,Qing-Qing Cai,Dan Xie

DOI: https://doi.org/10.7150/thno.60140

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30958.].

medicine, research & experimental
Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

Yan-Ming Liu,Yue Cao,Ping-Sen Zhao,Liang-Yin Wu,Ya-Min Lu,Yu-Long Wang,Jia-Feng Zhao,Xin-Guang Liu

DOI: https://doi.org/10.7150/ijbs.72651

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.66915.].
PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells: Erratum

Xiaobai Liu,Jian Zheng,Yixue Xue,Hai Yu,Wei Gong,Ping Wang,Zhen Li,Yunhui Liu

DOI: https://doi.org/10.7150/thno.69398

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.21740.].

medicine, research & experimental
Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway: Erratum

Jingjing Liu,Hongsheng Liang,Saadia Khilji,Haitao Li,Dandan Song,Chen Chen,Xiaoxing Wang,Yiwei Zhang,Ning Zhao,Xina Li,Aili Gao

DOI: https://doi.org/10.7150/jca.86757

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.46697.].

oncology
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum

Kangpeng Jin,Yang Liu,Yuze Shi,Haitian Zhang,YuanYuan Sun,Guangyan Zhangyuan,Fei Wang,Weiwei Yu,Jincheng Wang,Xuewen Tao,Xin Chen,Wenjie Zhang,Beicheng Sun

DOI: https://doi.org/10.7150/thno.73372

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.42658.].

medicine, research & experimental
[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-02-21

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].

medicine, research & experimental

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis

LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer: Erratum

Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum

EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Erratum: Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

[Corrigendum] PRIMA‐1 met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‐ULK1‐Vps34 signaling cascade

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis: Erratum

Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells: Erratum

Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway: Erratum

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum

[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma